Ibex Investors’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-262
| Closed | -$675K | – | 47 |
|
|
2021
Q4 | $675K | Sell |
262
-453
| -63% | -$1.17M | 0.23% | 32 |
|
|
2021
Q3 | $3.28M | Sell |
715
-256
| -26% | -$1.17M | 0.69% | 12 |
|
|
2021
Q2 | $6.68M | Sell |
971
-1,246
| -56% | -$8.57M | 2.48% | 5 |
|
|
2021
Q1 | $16.2M | Buy |
2,217
+324
| +17% | +$2.37M | 5.57% | 7 |
|
|
2020
Q4 | $15.3M | Buy |
1,893
+17
| +0.9% | +$137K | 6.1% | 8 |
|
|
2020
Q3 | $19.2M | Buy |
1,876
+6
| +0.3% | +$61.3K | 10.09% | 3 |
|
|
2020
Q2 | $12.5M | Buy |
1,870
+20
| +1% | +$134K | 5.95% | 6 |
|
|
2020
Q1 | $8.38M | Buy |
1,850
+97
| +6% | +$439K | 8.44% | 7 |
|
|
2019
Q4 | $10.6M | Sell |
1,753
-104
| -6% | -$631K | 0.2% | 7 |
|
|
2019
Q3 | $13.1M | Sell |
1,857
-10
| -0.5% | -$70.4K | 0.82% | 7 |
|
|
2019
Q2 | $12.1K | Buy |
1,867
+891
| +91% | +$5.79K | 0.99% | 8 |
|
|
2019
Q1 | $8.11M | Buy |
976
+37
| +4% | +$307K | 0.72% | 8 |
|
|
2018
Q4 | $5.21M | Buy |
939
+412
| +78% | +$2.29M | 0.85% | 7 |
|
|
2018
Q3 | $4.65M | Buy |
527
+27
| +5% | +$238K | 2.58% | 10 |
|
|
2018
Q2 | $4.27M | Buy |
500
+49
| +11% | +$418K | 2.42% | 11 |
|
|
2018
Q1 | $2.32M | Buy |
451
+7
| +2% | +$36.1K | 1.91% | 13 |
|
|
2017
Q4 | $2.28M | Buy |
+444
| New | +$2.28M | 1.33% | 9 |
|